Premium
Pharmaceutical companies’ profit pools will likely move away from manufacturing to care as they re-imagine themselves as service providers and not just pill suppliers, Cipla Ltd global chief executive Umang Vohra said on Friday. In fact, the shift is already happening in the industry with the advent of healthcare aggregators, Vohra ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
